Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities EXEL - Exelixis, Inc.
-27 M
LAST VALUE
20.72%
2 YEAR CAGR
38.15%
5 YEAR CAGR
-1.73%
10 YEAR CAGR